Eyenovia (EYEN) News Today $0.51 -0.03 (-5.58%) (As of 09/17/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 Time Period EYEN Shares Are Trading Higher Today: What You Need To KnowSeptember 9, 2024 | msn.comFormosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for CommercializationSeptember 9, 2024 | prnewswire.comEyenovia Announces Taiwan Export License Approval to Commence Shipment of Clobetasol Propionate Ophthalmic Suspension (0.05%) to the U.S.September 5, 2024 | globenewswire.comEyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial OfficerSeptember 3, 2024 | globenewswire.comEyenovia, Inc. (NASDAQ:EYEN) CEO Michael M. Rowe Buys 27,071 SharesAugust 29, 2024 | insidertrades.comEyenovia, Inc. (NASDAQ:EYEN) CEO Michael M. Rowe Buys 50,000 SharesAugust 28, 2024 | insidertrades.comEyenovia Announces Closing of Public OfferingAugust 23, 2024 | globenewswire.comWhy Is Eye Disease Focused Eyenovia Stock Trading Higher On Thursday?August 22, 2024 | benzinga.comEyenovia Prices 12.85 Mln Shares At $0.40/Share; Stock TanksAugust 21, 2024 | markets.businessinsider.comWhy Eyenovia (EYEN) Stock Is Getting Hammered TodayAugust 21, 2024 | msn.comEyenovia Announces Pricing of $5.14 Million Public OfferingAugust 21, 2024 | globenewswire.comEyenovia, Inc. Announces Proposed Public OfferingAugust 20, 2024 | globenewswire.comEyenovia, Inc. (EYEN) Latest Stock News & Headlines - Yahoo FinanceAugust 16, 2024 | ca.finance.yahoo.comEyenovia, Inc.: Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateAugust 15, 2024 | finanznachrichten.deEyenovia, Inc. (NASDAQ:EYEN) Q2 2024 Earnings Call TranscriptAugust 14, 2024 | msn.comEyenovia to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual ConferenceAugust 14, 2024 | finance.yahoo.comEyenovia, Inc. (EYEN) Q2 2024 Earnings Call TranscriptAugust 13, 2024 | seekingalpha.comEYEN Stock Earnings: Eyenovia Misses EPS, Misses Revenue for Q2 2024August 12, 2024 | investorplace.comEyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateAugust 12, 2024 | globenewswire.comEyenovia to Report Second Quarter 2024 Results on Monday, August 12thAugust 8, 2024 | globenewswire.comEyenovia and Formosa Pharmaceuticals Initiate Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S.August 7, 2024 | globenewswire.comFormosa Pharma and Eyenovia Announce Initiation of Co-Development of Clobetasol Propionate Ophthalmic Suspension, 0.05%, for the treatment of Acute Dry Eye Disease in United StatesAugust 7, 2024 | prnewswire.comEyenovia To Collaborate With SGN Nanopharma To Develop Treatment For Dry Eye DiseaseJuly 30, 2024 | markets.businessinsider.comEyenovia & SGN Nanopharma Announce Collaboration Agreement to Develop Novel Treatment for Chronic Dry Eye DiseaseJuly 30, 2024 | globenewswire.comEYEN Sep 2024 5.000 call (EYEN240920C00005000)July 29, 2024 | finance.yahoo.comEyenovia Collaborates With Senju Pharma For Potential Treatment For Chronic Dry EyeJuly 23, 2024 | markets.businessinsider.comEyenovia and Senju Pharmaceutical Co., Ltd. Sign Collaboration Agreement for Potential New Treatment for Chronic Dry Eye DiseaseJuly 23, 2024 | globenewswire.comEyenovia, Inc. (NASDAQ:EYEN) Major Shareholder Stuart M. Grant Buys 1,515,151 SharesJuly 4, 2024 | insidertrades.comEyenovia Announces Pricing of $5M Registered Direct OfferingJune 28, 2024 | globenewswire.comPeek Behind the Curtain: 7 Penny Stocks With Heavy Insider BuyingMay 23, 2024 | investorplace.comAll You Need to Know About Eyenovia Rating Upgrade to BuyMay 21, 2024 | markets.businessinsider.comEyenovia, Inc. (NASDAQ:EYEN) Q1 2024 Earnings Call TranscriptMay 17, 2024 | msn.comEyenovia Inc (EYEN) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and ...May 16, 2024 | finance.yahoo.comHC Wainwright Reaffirms "Buy" Rating for Eyenovia (NASDAQ:EYEN)HC Wainwright restated a "buy" rating and issued a $12.00 price target on shares of Eyenovia in a report on Thursday.May 16, 2024 | marketbeat.comEyenovia Reports First Quarter 2024 Financial Results and Provides Updates on its Myopia Phase III Program and its Two FDA Approved Commercial Products, Mydcombi and ClobetasolMay 15, 2024 | globenewswire.comEyenovia to Report First Quarter 2024 Results on Wednesday, May 15thMay 14, 2024 | globenewswire.comEarnings call: NovaBay reports record Avenova sales, eyes dry eye marketMay 12, 2024 | za.investing.comEyenovia, Inc.May 4, 2024 | cnn.comEyenovia, Inc.: Eyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi and Clobetasol Propionate Ophthalmic SuspensionApril 26, 2024 | finanznachrichten.deEyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi™ and Clobetasol Propionate Ophthalmic SuspensionApril 25, 2024 | globenewswire.comEyenovia (EYEN) Price Target Decreased by 24.29% to 7.21April 17, 2024 | msn.comEyenovia explores strategic alternatives amid new product developmentsApril 10, 2024 | investing.comEyenovia Shares Fall More Than 14% After Company Says It Is Exploring SaleApril 8, 2024 | marketwatch.comEyenovia Explores Options, Including Potential SaleApril 8, 2024 | marketwatch.comEyenovia Announces Updated Strategy and Corporate Priorities to Focus on Shareholder Value Generation and Immediate Commercial OpportunitiesApril 8, 2024 | globenewswire.comEyenovia IncApril 5, 2024 | reuters.comLenz Therapeutics’ Eye Drop Helps Improve Vision in Late-Stage StudyApril 4, 2024 | msn.comEyenovia to Feature its Suite of Commercial Products and the Optejet Dispenser at Upcoming National Eyecare MeetingsApril 3, 2024 | globenewswire.comStuart M. Grant Acquires 100,000 Shares of Eyenovia, Inc. (NASDAQ:EYEN) StockMarch 30, 2024 | insidertrades.comBrokers Set Expectations for Eyenovia, Inc.'s Q2 2024 Earnings (NASDAQ:EYEN)Eyenovia, Inc. (NASDAQ:EYEN - Free Report) - Research analysts at HC Wainwright issued their Q2 2024 earnings per share estimates for shares of Eyenovia in a report released on Tuesday, March 19th. HC Wainwright analyst M. Caufield expects that the company will earn ($0.19) per share for the quarMarch 22, 2024 | marketbeat.com Get Eyenovia News Delivered to You Automatically Sign up to receive the latest news and ratings for EYEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon Musk’s chilling warning for humanity (Ad)The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern border is a travesty, but the 'invasion' I've found will have 10 times greater effects on our economy, and ultimately our way of life. Go here to see why. EYEN Media Mentions By Week EYEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EYEN News Sentiment▼0.960.68▲Average Medical News Sentiment EYEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EYEN Articles This Week▼22▲EYEN Articles Average Week Get Eyenovia News Delivered to You Automatically Sign up to receive the latest news and ratings for EYEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MRKR News Today FBLG News Today SGMT News Today CASI News Today PDSB News Today PYRGF News Today CRVO News Today INMB News Today ANIX News Today DERM News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EYEN) was last updated on 9/17/2024 by MarketBeat.com Staff From Our PartnersGrab this ETF paying a huge 22% dividendLet's do a little math here... To double your money at a 3% rate of return, you would need around 23 years....Investors Alley | SponsoredNvidia needs these 3 companies on a new $1 trillion SuperprojectNvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And i...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | SponsoredJeff Bezos Just Humiliated Elon MuskThe Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eyenovia, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eyenovia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
